ReviewBritish journal of cancer2025

An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells.

Che-Yuan Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.